Formulating the Best Approach for Tablets...Ali Rajabi-Siahboomi
| Publicado en: | Pharmaceutical Technology Europe Vol. 34; no. 4; pp. 19 - 22 |
|---|---|
| Autor principal: | |
| Formato: | interview pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Apr2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156442415&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 156442415 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Apr2022 vid: 34 iid: 4 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 156442415 156442415 156442415 156442415 ppf: 19 ppct: 3 formats: fmt: @attributes: type: P tig: atl: Formulating the Best Approach for Tablets...Ali Rajabi-Siahboomi aug: au: Thomas, Felicity sug: subj: Tablets Chemistry, Pharmaceutical Administrative Personnel Pharmaceutical Companies Drug Development Success Patient Safety United States Food and Drug Administration Drug Approval Artificial Intelligence pubtype: Trade Publication doctype: interview pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|